Clinical Trial Update: Plasma cfDNA Fragmentomics for Early pNET Detection and Differential Diagnosis of Solid Pancreatic Tumors

View source ↗

Summary

A clinical trial sponsored by Fudan University is recruiting to evaluate plasma cfDNA fragmentomics for early detection of pancreatic neuroendocrine tumors and …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pancreatic Neoplasms
• Pancreatic Neuroendocrine Tumor

Snippet

Sponsor: Fudan University | Conditions: Pancreatic Neuroendocrine Tumor, Solid Pancreatic Neoplasms | Status: RECRUITING